ApolloBio
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Boston, Massachusetts, United StatesPhone Number
+86 1085711134Website
www.apollobio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ApolloBio
ApolloBio Corp. (NEEQ: 430187) is a leading Chinese biomedical company committed to research and development of innovative new medicines, accessing such new medicines through in-licensing, and additionally providing medical services. ApolloBio Corp. is focused on pharmaceutical products with significant market potential in China in the field of oncology; providing efficient access for American biomedical companies to enter into the Chinese market; and aiming to bring the newest and best medicines across the globe to the Chinese people.Explore more
Popular SearchesApolloBio CorpApollo Biosciences IncSIC Code 28,283NAICS Code 32,325Show moreApolloBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ApolloBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if ApolloBio is spiking on competitors!
Earning: See what the market has to say on ApolloBio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at ApolloBio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if ApolloBio has recently received funding, and reach out quickly before it becomes old news!
ApolloBio, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if ApolloBio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once ApolloBio has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when ApolloBio launches new products
Recommended Actions
Reach out to Masked Content who joined ApolloBio as Masked Content
Find 2 more new buyers
Compare Similar Companies to ApolloBio
Compare insights from companies similar to ApolloBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ApolloBio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ApolloBio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ApolloBio.
ApolloBio Tech Stack
A closer look at the technologies used by ApolloBio
See more technologies
ApolloBio News & Media
Tocagen Closes Previously Announced License Agreement with ApolloBio to Develop and Commercialize Toca 511 & Toca FC in Greater China
SAN DIEGO and BEIJING, July 9, 2018 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, and Beijing Apollo Venus Biomedical Technology Limited, an affiliate of ApolloBio Corp., a biopharmaceutical company focused on oncology (collectively, "ApolloBio"), today announced the closing of an agreement providing ApolloBio with the exclusive right to develop and commercialize Toca 511 & Toca FC within the greater China region. ApolloBio has garnered allTocagen and ApolloBio Enter License Agreement to Develop and Commercialize Toca 511 & Toca FC in the Greater China Region
Tocagen eligible to receive up to $127 million in upfront payment, development and commercial milestones, plus additional double-digit tiered sales royalties Upfront and near-term development milestones payments total up to $20 million SAN DIEGO and BEIJING, April 19, 2018 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, and Beijing Apollo Venus Biomedical Technology Limited, an affiliate of ApolloBio Corp. (NEEQ: 430187), a biopharmaceuticalInovio Enters License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China
Inovio to receive $23 million in upfront payment; an additional $20 million in future regulatory milestone payments and double-digit tiered royalties on sales
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding ApolloBio
Sign Up For FreeTo access detailed company insights
ApolloBio Corp. (NEEQ: 430187) is a leading Chinese biomedical company committed to research and development of innovative new medicines, accessing such new medicines through in-licensing, and additionally providing medical services. ApolloBio Corp. is focused on pharmaceutical products with significant market potential in China in the field of onc... Read More
